PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of North Carolina, Chapel Hill, North Carolina (L.L.).\', \'Foundation for the National Institutes of Health, North Bethesda, Maryland (S.J.A.).\', \'University of California, Los Angeles, Los Angeles, California (J.S.C.).\', \'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (E.S.H., S.W.R.).\', \'National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland (L.A.R.).\', \'Novartis Pharma, Basel, Switzerland (E.A.H.).\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7326/M21-1269
?:hasPublicationType
?:journal
  • Annals of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 34181444
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.466
?:rankingScore_hIndex
  • 349
is ?:relation_isRelatedTo_publication of
?:title
  • Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34181444>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34181444>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all